Epigenetic modulation of the immune function: A potential target for tolerance

Epigenetics

Volumn 8, Issue 7, 2013, Pages 694-702

  Suárez Álvarez, Beatriz ^a,c   Raneros, Aroa Baragaño ^a   Ortega, Francisco ^a,b   López Larrea, Carlos ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Section of Nephrology   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

DNA methylation; Histone modifications; Rejection; Tolerance

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA METHYLTRANSFERASE; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GRANZYME B; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; PROGRAMMED DEATH 1 RECEPTOR; T6 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ALLOIMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; DENDRITIC CELL; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAFT REJECTION; HISTONE MODIFICATION; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLASTICITY; TRANSPLANTATION; UPREGULATION;

EID: 84879624722     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.25201     Document Type: Article

References (96)

1. Rodriguez-Cortez VC, Hernando H, de la Rica L, Vento R, Ballestar E. Epigenomic deregulation in the immune system. Epigenomics 2011; 3:697-713; PMID:22126290; http://dx.doi.org/10.2217/epi.11.99
2. Suarez-Alvarez B, Rodriguez RM, Fraga MF, López-Larrea C. DNA methylation: a promising landscape for immune system-related diseases. Trends Genet 2012; 28:506-14; PMID:22824525; http://dx.doi. org/10.1016/j.tig.2012.06.005
3. Schildberg FA, Hagmann CA, Böhnert V, Tolba RH. Improved transplantation outcome by epigenetic changes. Transpl Immunol 2010; 23:104-10; PMID:20471480; http://dx.doi.org/10.1016/j. trim.2010.05.001
4. McCaughan JA, McKnight AJ, Courtney AE, Maxwell AP. Epigenetics: time to translate into transplantation. Transplantation 2012; 94:1-7; PMID:22437848; http://dx.doi.org/10.1097/TP.0b013e31824db9bd
5. Rodriguez RM, Suarez-Alvarez B, Salvanés R, Muro M, Martínez-Camblor P, Colado E, et al. DNA methylation dynamics in blood after hematopoietic cell transplant. PLoS One 2013; 8:e56931; PMID:23451113; http://dx.doi.org/10.1371/journal.pone.0056931
6. Kulis M, Esteller M. DNA methylation and cancer. Adv Genet 2010; 70:27-56; PMID:20920744; http://dx.doi.org/10.1016/B978-0-12-380866-0.60002-2
7. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011; 21:381-95; PMID:21321607; http://dx.doi.org/10.1038/cr.2011.22
8. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, et al.; ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489:57-74; PMID:22955616; http://dx.doi.org/10.1038/nature11247
9. Chadwick LH. The NIH Roadmap Epigenomics Program data resource. Epigenomics 2012; 4:317-24; PMID:22690667; http://dx.doi.org/10.2217/epi.12.18
10. Adams D, Altucci L, Antonarakis SE, Ballesteros J, Beck S, Bird A, et al. BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol 2012; 30:224-6; PMID:22398613; http://dx.doi. org/10.1038/nbt.2153
11. Merad M, Collin M, Bromberg J. Dendritic cell homeostasis and trafficking in transplantation. Trends Immunol 2007; 28:353-9; PMID:17618832; http://dx.doi.org/10.1016/j.it.2007.06.003
12. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449:419-26; PMID:17898760; http://dx.doi.org/10.1038/nature06175
13. Bullwinkel J, Lüdemann A, Debarry J, Singh PB. Epigenotype switching at the CD14 and CD209 genes during differentiation of human monocytes to dendritic cells. Epigenetics 2011; 6:45-51; PMID:20818162; http://dx.doi.org/10.4161/epi.6.1.13314
14. Huang Y, Min S, Lui Y, Sun J, Su X, Liu Y, et al. Global mapping of H3K4me3 and H3K27me3 reveals chromatin state-based regulation of human monocytederived dendritic cells in different environments. Genes Immun 2012; 13:311-20; PMID:22278394; http://dx.doi.org/10.1038/gene.2011.87
15. Moreau A, Varey E, Bouchet-Delbos L, Cuturi MC. Cell therapy using tolerogenic dendritic cells in transplantation. Transplant Res 2012; 1:13; PMID:23369513; http://dx.doi.org/10.1186/2047-1440-1-13
16. Frikeche J, Peric Z, Brissot E, Grégoire M, Gaugler B, Mohty M. Impact of HDAC inhibitors on dendritic cell functions. Exp Hematol 2012; 40:783-91; PMID:22728031; http://dx.doi.org/10.1016/j. exphem.2012.06.008
17. Nencioni A, Beck J, Werth D, Grünebach F, Patrone F, Ballestrero A, et al. Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clin Cancer Res 2007; 13:3933-41; PMID:17606727; http://dx.doi.org/10.1158/1078-0432.CCR-06-2903
18. Wang B, Morinobu A, Horiuchi M, Liu J, Kumagai S. Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. Cell Immunol 2008; 253:54-8; PMID:18522857; http://dx.doi. org/10.1016/j.cellimm.2008.04.016
19. Villagra A, Cheng F, Wang HW, Suarez I, Glozak M, Maurin M, et al. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat Immunol 2009; 10:92-100; PMID:19011628; http://dx.doi.org/10.1038/ni.1673
20. Luckheeram RV, Zhou R, Verma AD, Xia B. CD4+T cells: differentiation and functions. Clin Dev Immunol 2012; 2012:925135; PMID:22474485; http://dx.doi. org/10.1155/2012/925135
21. Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 2009; 9:91-105; PMID:19151746; http://dx.doi. org/10.1038/nri2487
22. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009; 30:155-67; PMID:19144320; http://dx.doi. org/10.1016/j.immuni.2008.12.009
23. Schoenborn JR, Dorschner MO, Sekimata M, Santer DM, Shnyreva M, Fitzpatrick DR, et al. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat Immunol 2007; 8:732-42; PMID:17546033; http://dx.doi.org/10.1038/ni1474
24. Santangelo S, Cousins DJ, Winkelmann N, Triantaphyllopoulos K, Staynov DZ. Chromatin structure and DNA methylation of the IL-4 gene in human T(H)2 cells. Chromosome Res 2009; 17:485-96; PMID:19521787; http://dx.doi.org/10.1007/s10577-009-9040-3
25. Aune TM, Collins PL, Chang S. Epigenetics and T helper 1 differentiation. Immunology 2009; 126:299-305; PMID:19178593; http://dx.doi.org/10.1111/j.1365-2567.2008.03026.x
26. Allan RS, Zueva E, Cammas F, Schreiber HA, Masson V, Belz GT, et al. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment. Nature 2012; 487:249-53; PMID:22763435; http://dx.doi. org/10.1038/nature11173
27. Muranski P, Restifo NP. Essentials of Th17 cell commitment and plasticity. Blood 2013; 121:2402-14; PMID:23325835; http://dx.doi.org/10.1182/blood-2012-09-378653
28. Ohkura N, Hamaguchi M, Morikawa H, Sugimura K, Tanaka A, Ito Y, et al. T cell receptor stimulationinduced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 2012; 37:785-99; PMID:23123060; http://dx.doi.org/10.1016/j.immuni. 2012. 09.010
29. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D'Addio F, Mfarrej B, Donnarumma M, et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008; 205:3133-44; PMID:19047438; http://dx.doi.org/10.1084/jem.20081937
30. Hanidziar D, Koulmanda M. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance. Curr Opin Organ Transplant 2010; 15:411-5; PMID:20613526; http://dx.doi. org/10.1097/MOT.0b013e32833b7929
31. Issa F, Chandrasekharan D, Wood KJ. Regulatory T cells as modulators of chronic allograft dysfunction. Curr Opin Immunol 2011; 23:648-54; PMID:21752619; http://dx.doi.org/10.1016/j.coi.2011.06.005
32. Cohen CJ, Crome SQ, MacDonald KG, Dai EL, Mager DL, Levings MK. Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J Immunol 2011; 187:5615-26; PMID:22048764; http://dx.doi.org/10.4049/jimmunol. 1101058
33. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009; 30:616-25; PMID:19464984; http://dx.doi. org/10.1016/j.immuni.2009.04.009
34. Baron U, Floess S, Wieczorek G, Baumann K, Grützkau A, Dong J, et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007; 37:2378-89; PMID:17694575; http://dx.doi.org/10.1002/eji.200737594
35. Lal G, Zhang N, van der Touw W, Ding Y, Ju W, Bottinger EP, et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 2009; 182:259-73; PMID:19109157
36. van Loosdregt J, Vercoulen Y, Guichelaar T, Gent YY, Beekman JM, van Beekum O, et al. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 2010; 115:965-74; PMID:19996091; http://dx.doi.org/10.1182/blood-2009-02-207118
37. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. Helper T cell diversity and plasticity. Curr Opin Immunol 2012; 24:297-302; PMID:22341735; http://dx.doi.org/10.1016/j.coi.2012.01.014
38. Hirahara K, Vahedi G, Ghoreschi K, Yang XP, Nakayamada S, Kanno Y, et al. Helper T-cell differentiation and plasticity: insights from epigenetics. Immunology 2011; 134:235-45; PMID:21977994; http://dx.doi.org/10.1111/j.1365-2567.2011.03483.x
39. Murphy KM, Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol 2010; 11:674-80; PMID:20644573; http://dx.doi.org/10.1038/ni.1899
40. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009; 30:646-55; PMID:19464987; http://dx.doi.org/10.1016/j. immuni.2009.05.001
41. Ye J, Su X, Hsueh EC, Zhang Y, Koenig JM, Hoft DF, et al. Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function. Eur J Immunol 2011; 41:936-51; PMID:21381020; http://dx.doi. org/10.1002/eji.201040682
42. Issa F, Robb RJ, Wood KJ. The where and when of T cell regulation in transplantation. Trends Immunol 2013; 34:107-13; PMID:23228885; http://dx.doi. org/10.1016/j.it.2012.11.003
43. Schmidl C, Hansmann L, Andreesen R, Edinger M, Hoffmann P, Rehli M. Epigenetic reprogramming of the RORC locus during in vitro expansion is a distinctive feature of human memory but not naïve Treg. Eur J Immunol 2011; 41:1491-8; PMID:21469109; http://dx.doi.org/10.1002/eji.201041067
44. Miyao T, Floess S, Setoguchi R, Luche H, Fehling HJ, Waldmann H, et al. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012; 36:262-75; PMID:22326580; http://dx.doi.org/10.1016/j.immuni.2011.12.012
45. Bestard O, Cuñetti L, Cruzado JM, Lucia M, Valdez R, Olek S, et al. Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome. Am J Transplant 2011; 11:2162-72; PMID:21749644; http://dx.doi. org/10.1111/j.1600-6143.2011.03633.x
46. Beier UH, Wang L, Han R, Akimova T, Liu Y, Hancock WW. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci Signal 2012; 5:ra45; PMID:22715468; http://dx.doi. org/10.1126/scisignal.2002873
47. Beier UH, Wang L, Hancock WW. Combination of isoform-selective histone/protein deacetylase inhibitors improves Foxp3+ T-regulatory cell function. Cell Cycle 2012; 11:3351-2; PMID:22918251; http://dx.doi. org/10.4161/cc.21876
48. Page AJ, Ford ML, Kirk AD. Memory T-cell-specific therapeutics in organ transplantation. Curr Opin Organ Transplant 2009; 14:643-9; PMID:19779342; http://dx.doi.org/10.1097/MOT.0b013e328332bd4a
49. Weng NP, Araki Y, Subedi K. The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat Rev Immunol 2012; 12:306-15; PMID:22421787; http://dx.doi. org/10.1038/nri3173
50. Steinfelder S, Floess S, Engelbert D, Haeringer B, Baron U, Rivino L, et al. Epigenetic modification of the human CCR6 gene is associated with stable CCR6 expression in T cells. Blood 2011; 117:2839-46; PMID:21228329; http://dx.doi.org/10.1182/blood-2010-06-293027
51. Araki Y, Fann M, Wersto R, Weng NP. Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). J Immunol 2008; 180:8102-8; PMID:18523274
52. Araki Y, Wang Z, Zang C, Wood WH 3rd, Schones D, Cui K, et al. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity 2009; 30:912-25; PMID:19523850; http://dx.doi.org/10.1016/j.immuni.2009.05.006
53. Youngblood B, Oestreich KJ, Ha SJ, Duraiswamy J, Akondy RS, West EE, et al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity 2011; 35:400-12; PMID:21943489; http://dx.doi. org/10.1016/j.immuni.2011.06.015
54. Youngblood B, Wherry EJ, Ahmed R. Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells. Curr Opin HIV AIDS 2012; 7:50-7; PMID:22134341; http://dx.doi. org/10.1097/COH.0b013e32834ddcf2
55. Villard J. The role of natural killer cells in human solid organ and tissue transplantation. J Innate Immun 2011; 3:395-402; PMID:21411978; http://dx.doi. org/10.1159/000324400
56. Ogbomo H, Michaelis M, Kreuter J, Doerr HW, Cinatl J Jr. Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett 2007; 581:1317-22; PMID:17349632; http://dx.doi.org/10.1016/j.febslet. 2007. 02.045
57. Schmiedel BJ, Arélin V, Gruenebach F, Krusch M, Schmidt SM, Salih HR. Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation. Int J Cancer 2011; 128:2911-22; PMID:20960460; http://dx.doi. org/10.1002/ijc.25635
58. Li G, Yu M, Weyand CM, Goronzy JJ. Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood 2009; 114:3422-30; PMID:19628706; http://dx.doi.org/10.1182/blood-2009-01-200170
59. Fernández-Sánchez A, Baragaño Raneros A, Carvajal Palao R, Sanz AB, Ortiz A, Ortega F, et al. DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells. Epigenetics 2013; 8:66-78; PMID:23235109; http://dx.doi.org/10.4161/epi.23115
60. Zarkhin V, Sarwal MM. The coin toss of B cells in rejection and tolerance: danger versus defense. Semin Immunol 2012; 24:86-91; PMID:22035649; http://dx.doi.org/10.1016/j.smim.2011.09.003
61. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, et al.; Immune Tolerance Network ST507 Study Group. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120:1836-47; PMID:20501946; http://dx.doi.org/10.1172/JCI39933
62. Ramírez J, Lukin K, Hagman J. From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment. Curr Opin Immunol 2010; 22:177-84; PMID:20207529; http://dx.doi.org/10.1016/j. coi.2010.02.003
63. Santos P, Arumemi F, Park KS, Borghesi L, Milcarek C. Transcriptional and epigenetic regulation of B cell development. Immunol Res 2011; 50:105-12; PMID:21717070; http://dx.doi.org/10.1007/s12026-011-8225-y
64. Parra M. Epigenetic events during B lymphocyte development. Epigenetics 2009; 4:462-8; PMID:19875937; http://dx.doi.org/10.4161/epi.4.7.10052
65. Lee ST, Xiao Y, Muench MO, Xiao J, Fomin ME, Wiencke JK, et al. A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network. Nucleic Acids Res 2012; 40:11339-51; PMID:23074194; http://dx.doi.org/10.1093/nar/gks957
66. McManus S, Ebert A, Salvagiotto G, Medvedovic J, Sun Q, Tamir I, et al. The transcription factor Pax5 regulates its target genes by recruiting chromatinmodifying proteins in committed B cells. EMBO J 2011; 30:2388-404; PMID:21552207; http://dx.doi. org/10.1038/emboj.2011.140
67. Amaravadi L, Klemsz MJ. DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol 1999; 18:875-84; PMID:10619599; http://dx.doi.org/10.1089/104454999314737
68. Maier H, Ostraat R, Gao H, Fields S, Shinton SA, Medina KL, et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat Immunol 2004; 5:1069-77; PMID:15361869; http://dx.doi.org/10.1038/ni1119
69. Walter K, Bonifer C, Tagoh H. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus. Blood 2008; 112:1673-82; PMID:18552207; http://dx.doi. org/10.1182/blood-2008-02-142786
70. Matheson LS, Corcoran AE. Local and global epigenetic regulation of V(D)J recombination. Curr Top Microbiol Immunol 2012; 356:65-89; PMID:21695632; http://dx.doi.org/10.1007/82_2011_137
71. Shaknovich R, Cerchietti L, Tsikitas L, Kormaksson M, De S, Figueroa ME, et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 2011; 118:3559-69; PMID:21828137; http://dx.doi. org/10.1182/blood-2011-06-357996
72. Teperek-Tkacz M, Pasque V, Gentsch G, Ferguson-Smith AC. Epigenetic reprogramming: is deamination key to active DNA demethylation? Reproduction 2011; 142:621-32; PMID:21911441; http://dx.doi. org/10.1530/REP-11-0148
73. Kuraoka M, Holl TM, Liao D, Womble M, Cain DW, Reynolds AE, et al. Activation-induced cytidine deaminase mediates central tolerance in B cells. Proc Natl Acad Sci U S A 2011; 108:11560-5; PMID:21700885; http://dx.doi.org/10.1073/pnas.1102571108
74. Su ST, Ying HY, Chiu YK, Lin FR, Chen MY, Lin KI. Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation. Mol Cell Biol 2009; 29:1421-31; PMID:19124609; http://dx.doi.org/10.1128/MCB.01158-08
75. Roedder S, Vitalone M, Khatri P, Sarwal MM. Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med 2011; 3:37; PMID:21658299; http://dx.doi. org/10.1186/gm253
76. Naesens M, Sarwal MM. Molecular diagnostics in transplantation. Nat Rev Nephrol 2010; 6:614-28; PMID:20736923; http://dx.doi.org/10.1038/nrneph. 2010. 113
77. Viklicky O, Krystufkova E, Brabcova I, Sekerkova A, Wohlfahrt P, Hribova P, et al. B-cell-related biomarkers of tolerance are up-regulated in rejection-free kidney transplant recipients. Transplantation 2013; 95:148-54; PMID:23222918; http://dx.doi.org/10.1097/TP.0b013e3182789a24
78. Chowdhury P, Hernandez-Fuentes MP. Noninvasive biomarkers to guide management following renal transplantation: the need for a multiplatform approach. Curr Opin Organ Transplant 2013; 18:1-5; PMID:23283248; http://dx.doi.org/10.1097/MOT.0b013e32835c8025
79. Li L, Khatri P, Sigdel TK, Tran T, Ying L, Vitalone MJ, et al. A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant 2012; 12:2710-8; PMID:23009139; http://dx.doi. org/10.1111/j.1600-6143.2012.04253.x
80. Londoño MC, Danger R, Giral M, Soulillou JP, Sánchez-Fueyo A, Brouard S. A need for biomarkers of operational tolerance in liver and kidney transplantation. Am J Transplant 2012; 12:1370-7; PMID:22486792; http://dx.doi.org/10.1111/j.1600-6143. 2012.04035.x
81. Lozano JJ, Pallier A, Martinez-Llordella M, Danger R, López M, Giral M, et al. Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant 2011; 11:1916-26; PMID:21827613; http://dx.doi.org/10.1111/j.1600-6143.2011.03638.x
82. Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13:679-92; PMID:22945394; http://dx.doi. org/10.1038/nrg3270
83. Ho AS, Turcan S, Chan TA. Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management. Onco Targets Ther 2013; 6:223-32; PMID:23569385
84. Wu SL, Pan CE, Yu L, Meng KW. Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model. Transplant Proc 2005; 37:2354-9; PMID:15964415; http://dx.doi. org/10.1016/j.transproceed.2005.03.112
85. Kinugasa F, Nagatomi I, Nakanishi T, Noto T, Mori H, Matsuoka H, et al. Effect of the immunosuppressant histone deacetylase inhibitor FR276457 in a canine renal transplant model. Transpl Immunol 2009; 21:198-202; PMID:19409992; http://dx.doi. org/10.1016/j.trim.2009.04.006
86. Zhang X, Han S, Kang Y, Guo M, Hong S, Liu F, et al. SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection. Cell Mol Immunol 2012; 9:390-8; PMID:22922441; http://dx.doi.org/10.1038/cmi.2012.28
87. Bharti AC, Panigrahi A, Sharma PK, Gupta N, Kumar R, Shukla S, et al. Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplant: an in vitro analysis. Exp Clin Transplant 2010; 8:161-71; PMID:20565374
88. Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol 2012; 12:417-30; PMID:22627860; http://dx.doi.org/10.1038/nri3227
89. Sagoo P, Lombardi G, Lechler RI. Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol 2012; 3:184; PMID:22811678; http://dx.doi.org/10.3389/fimmu.2012.00184
90. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity 2013; 38:414-23; PMID:23521883; http://dx.doi. org/10.1016/j.immuni.2013.03.002
91. Casiraghi F, Perico N, Remuzzi G. Mesenchymal stromal cells to promote solid organ transplantation tolerance. Curr Opin Organ Transplant 2013; 18:51-8; PMID:23254705; http://dx.doi.org/10.1097/MOT.0b013e32835c5016
92. Wang Y, Chen T, Yan H, Qi H, Deng C, Ye T, et al. Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells. [Epub ahead of print]. J Cell Biochem 2013; PMID:23564418; http://dx.doi.org/10.1002/jcb.24569
93. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010; 468:1119-23; PMID:21068722; http://dx.doi.org/10.1038/nature09589
94. Gregory DJ, Mikhaylova L, Fedulov AV. Selective DNA demethylation by fusion of TDG with a sequencespecific DNA-binding domain. Epigenetics 2012; 7:344-9; PMID:22419066; http://dx.doi.org/10.4161/epi.19509
95. Dalton SR, Bellacosa A. DNA demethylation by TDG. Epigenomics 2012; 4:459-67; PMID:22920184; http://dx.doi.org/10.2217/epi.12.36
96. Rivenbark AG, Stolzenburg S, Beltran AS, Yuan X, Rots MG, Strahl BD, et al. Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics 2012; 7:350-60; PMID:22419067; http://dx.doi.org/10.4161/epi.19507